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KEY POINTS
 Oral health is important since the mouth is the gateway to the human body. Bacteria are
always present in the oral cavity and when not frequently removed the dental plaque bio-
film leads to the development of oral disease.
 Over the past decades, the use of mouthwashes has become customary, usually following
mechanical plaque biofilm control.
 Although people in industrialized countries use various oral hygiene products with the
expectation of an oral health benefit, it is important that sufficient scientific evidence exists
to support such claims.
 This meta-review summarized and appraised the current state of evidence that was based
on systematic reviews, with respect to the efficacy of various active ingredients of over-
the-counter chemotherapeutic mouthwash formulations for plaque control and managing
gingivitis.
 Evidence suggests that a mouthwash containing chlorhexidine (CHX) is the first choice.
The most reliable alternative for plaque control is essential oil (EO). No difference between
CHX and EO with respect to gingivitis was observed.Conflict of Interest and Source of Funding Statement: The authors declare that they have no
conflict of interest. This study was self-funded by the authors and their institutions. Ethical
approval was not required. D.E. Slot and F.A. Van der Weijden have formerly received external
advisor fees, lecturer fees, or research grants from companies that produce mouthwash prod-
ucts. Among these were Colgate, Dentaid, GABA, Lactona, Oral-B, Philips, Procter & Gamble,
Sara Lee, Sunstar, and Unilever. Similarly, S.G. Ciancio has interacted with Colgate, Johnson &
Johnson, St. Renatus, Phoenix Dental, and Sunstar.
a Department of Periodontology, Academic Centre for Dentistry Amsterdam (ACTA), University
of Amsterdam, VU University Amsterdam, Amsterdam, The Netherlands; b Department of Peri-
odontics and Endodontics, University at Buffalo, The State University of New York, Buffalo,
NY, USA
* Corresponding author. Academic Centre for Dentistry Amsterdam (ACTA), Department of
Periodontology, Gustav Mahlerlaan 3004, 1081 LA, Amsterdam, The Netherlands.
E-mail address: ga.vd.weijden@acta.nl
Dent Clin N Am 59 (2015) 799–829
http://dx.doi.org/10.1016/j.cden.2015.06.002 dental.theclinics.com
0011-8532/15/$ – see front matter  2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Van der Weijden et al800INTRODUCTION
The need to prevent human disease is well recognized and is related to making the
occurrence or progression of a disease process unlikely or impossible. Oral health
is important because the mouth is the gateway to the human body. Bacteria are
always present in the oral cavity and when not frequently removed, the dental plaque
biofilm leads to the development of oral disease. The merits of daily oral hygiene to
oral health have long been understood.1 Studies of tooth cleaning suggest that despite
technological innovations, the level of mechanical oral hygiene practice is
inadequate.2–4
The principle that plaque biofilm is the major etiologic factor causing gingivitis
provides the justification for the use of antimicrobial mouth rinses.5 The practice
of mouth rinsing has been in use by humans for more than 2000 years. The
first mouthwash advocated for dental plaque reduction seems to be urine from a
child or, even better, from a newborn baby.6 In the 1880s, Willoughby D. Miller
(a dentist trained in microbiology) was the first to suggest the use of an anti-
microbial mouthwash containing phenolic compounds to combat gingival
inflammation.7 Over the past decades, the use of mouthwashes has become
customary, usually following mechanical plaque biofilm control. Mouthwashes are
an ideal vehicle in which to incorporate chemicals and are appreciated by the pub-
lic because of their ease of use, reduction of plaque biofilm, and breath-freshening
effect.8–10
With keen competition between individual manufacturers vying for a percentage of
this market, various claims for efficacy have been made, using numerous terms to
describe efficacy. Although people in industrialized countries use various oral hy-
giene products with the expectation of an oral health benefit, it is important that suf-
ficient scientific evidence exists to support such claims. Dental professionals have
choices and make decisions every day as they advise their patients.11 An
evidence-based clinical decision integrates and concisely summarizes all relevant
and important research evidence of acceptable quality that examines the same ther-
apeutic question. The model to guide clinical decisions begins with original single
random controlled clinical studies at its foundation. Syntheses (systematic reviews)
build up from these to integrate the best available evidence from these original
studies.12 At the next level, a synopsis summarizes the findings of high-quality sys-
tematic reviews.13,14 Meta-analyses (meta-review) in particular are appropriate for
describing whether the current evidence base is complete or incomplete. The quan-
titative evidence is synthesized from relevant previous systematic reviews. The
reason for including only systematic reviews is because this kind of research gener-
ally provides more evidence than separate empirical studies. Also in the presence of
a significant increase in systematic reviews, meta-reviews give the dental community
better guidance. From this perspective, it is a step forward in the direction of a clin-
ical guideline.15,16 Meta-reviews are a tool, a form of information, and guidance
based on research evidence that assists the clinician in formulating the answer
appropriate for each individual patient.11
Recently, 2 meta-reviews have been published that evaluate the efficacy
of home-care regimens for mechanical plaque removal (toothbrushes and inter-
dental cleaning devices) on plaque and gingivitis in adults.2,3 The purpose of this
article was to prepare a meta-review that summarizes the contemporary synthe-
sized evidence with respect to the efficacy and safety of home-care self-support
activities focusing on chemical agents in mouthwashes to manage plaque and
gingivitis.
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The protocol of this meta-review detailing the evaluation method was developed using
the AMSTAR17 (a measurement tool to assess systematic reviews) tool to ensure the
methodological quality of the review process.
Focused Question
What is the effect of mouthwashes and their various chemical ingredients for plaque
biofilm control in managing gingivitis in adults based on evidence gathered from exist-
ing systematic reviews?
Search Strategy
For the comprehensive search strategy, several electronic databases were queried.
Three Internet sources were used to search for appropriate articles that satisfied the
study purpose. These sources included the National Library of Medicine, Washing-
ton, DC (MEDLINE-PubMed), the Cochrane Library, which also includes the DARE
database of systematic reviews, and the evidence database of the American Dental
Association (ADA) Center for Evidence-based Dentistry. All 3 databases were
searched for eligible studies up to and including February 2015. The structured
search strategy was designed to include any systematic review published on mouth-
wash products. For details regarding the search terms used, see Box 1. All of the
reference lists of the selected studies were hand-searched for additional published
work that could possibly meet the eligibility criteria of the study. The PROSPERO
(2014) database, an international database of prospectively registered systematic
reviews, was checked for reviews in progress. Further unpublished work was not
sought.
Screening and Selection
Two reviewers (DES and EvdS) independently screened the titles and abstracts for
eligible articles. If eligibility aspects were present in the title, the article was selected
for further reading. If none of the eligibility aspects were mentioned in the title, the ab-
stract was read in detail to screen for suitability. Inclusion of titles, abstracts, and ul-
timately full texts was based initially on full agreement between the 2 reviewers (DES
and EvdS). In case of discrepancies, the final decision was made following discussion
with GAW. No attempt was made to blind the reviewers to names of authors or insti-
tutions and journals while making the assessment. Hand searching of reference lists of
reviews was conducted to ensure inclusion of additional published and potentiallyBox 1
Search terms used for PubMed-MEDLINE, Cochrane Library, and American Dental Association
Center for Evidence-based Dentistry
The search strategy was customized appropriately according to the database being searched,
taking into account differences in controlled vocabulary and syntax rules.
The following strategy was used in the search mouthwashes:
{[MeSH Terms] Mouthwashes OR [text words] Mouthwashes OR Mouthwash OR mouthwash*
OR mouthrinses OR mouthrinse}
Used filter/limits: systematic review OR meta-analysis
* Used as a truncation symbol.
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version was selected. At the outset of this meta-review, no attempt was made to sepa-
rate specific variables associated with mouthwashes.
Inclusion and Exclusion Criteria
The inclusion criteria were as follows:
 Systematic reviews (with or without a meta-analysis)
 Articles written in the English or Dutch language
 Reviews evaluating studies conducted on humans
 18 years old
 In good general health
 Intervention: mouthwashes and their various chemical ingredients for plaque
control and reducing gingivitis
The exclusion criteria were as follows:
 Orthodontic patients
 Dental implants
Data Extraction and Assessment of Heterogeneity
The articles that fulfilled all of the selection criteria were processed for data extraction.
Information extracted from the studies included publication details, focused ques-
tions, search results, descriptive or meta-analysis outcomes, and conclusions.
Systematic reviews were categorized by 2 authors (DES and EvdS) according to
various active ingredients of mouthwashes. Categorization was confirmed with a
second author (GAW). Disagreements between the reviewers were resolved by
discussion.
The heterogeneity across studies was detailed according to the following
factors:
 Study and subject characteristics
 Methodological heterogeneity (variability in review approach and risk of bias)
 Analysis performed (descriptive or meta-analysis)
Heterogeneity within the meta-analysis was tested by c2 test and the I2 statistical. A
c2 test resulting in a P<.1 was considered an indication of significant statistical hetero-
geneity. As a rough guide for assessing the possible magnitude of inconsistency
across studies, an I2 statistic of 0% to 40% was interpreted as not being important,
and with an I2 statistic higher than 40%, moderate (40%–80%) to considerable
(>80%) heterogeneity may be present.18
Quality Assessment
Two reviewers (DES and EvdS) estimated the risk of bias by scoring the reporting
and methodological quality of the included systematic reviews according to a com-
bination of items described by the PRISMA19 guideline for reporting systematic re-
views and the17 checklist for assessing the methodological quality of systematic
reviews. A list of 27 items was assessed, and if all individual items were given a pos-
itive rating by summing these items, an overall score of 100% was obtained. Only
systematic reviews including meta-analysis could achieve a full score of 100%.20
The estimated risk of bias was interpreted as follows: 0% to 40% may represent a
high risk of bias, 40% to 60% may represent a substantial risk of bias, 60% to
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risk of bias.3
Grading the ‘Body of Evidence’
The Grading of Recommendations Assessment, Development, and Evaluation
(GRADE) system, as proposed by the GRADE working group, was used to grade
the evidence emerging from this meta-review of systematic reviews.21 Two reviewers
(DES and GAW) rated the quality of the evidence as well as the strength of the recom-
mendations according to the following aspects: study design, risk of bias, consistency
and precision among outcomes, directness of results, detection of publication bias,
and magnitude of the effect.
RESULTS
Search and Selection Results
Fig. 1 describes the search process. A total of 306 unique articles were identified, from
which 17 full-text articles were obtained and screened to confirm eligibility. One study
was excluded because the data were summarized for a large variety of natural com-
pounds and did not allow for an evaluation of individual ingredients.22 Hand searching
of the reference lists from these articles did not reveal any additional suitable system-
atic reviews. Neither did a search of the PROSPERO (International Prospective
Register of Systematic Reviews) database (2014). Two papers by Gunsolley23,24 pro-
vided data on the same meta-analysis. As a result, a final 15 systematic reviews were
identified as being eligible for inclusion in this synopsis. Nine articles were identified
that evaluated the efficacy of single active ingredients, of which 2 reviewed more
than 1 ingredient.23,24,26 Five studies compared active ingredients, of which 2 also
contributed data for the singles active ingredients.27,28 In one publication, a combina-
tion of 2 active ingredients was systematically evaluated.29
Study Outcomes and Assessment of Heterogeneity
Considerable heterogeneity was observed in the 15 systematic reviews with respect
to the data bases searched, study and subject characteristics of the original individual
articles, description of inclusion and exclusion criteria, quality assessment scale used,
reporting of effect scores, presence of meta-analysis, and conclusions made.
Because of this heterogeneity, a sophisticated level of data combination and analysis
was neither possible nor indicated. A meta-analysis was therefore not undertaken. For
the purpose of this synopsis, a summary of the selected systematic reviews was cate-
gorized and is presented by various chemical ingredients and ordered by common
characteristics in Table 1.
Quality Assessment
Most reviews were considered to have a low to moderate estimated risk of bias
(Table 2). Two studies were estimated to have a substantial risk of bias.23–25 Critical
items in this evaluation were the development of a protocol “a priori” and its registra-
tion, including non-English literature, contacting authors for additional information,
grading obtained evidence, and the assessment of publication bias.
Active Ingredients
For details regarding the extracted data of the meta-analysis, difference of means, P
values, 95% confidence intervals, and test of heterogeneity, please see Table 3 for
Plaque Index scores and Table 4 for Gingival Index scores.
Final selection
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Fig. 1. Search and selection results.
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Alexidine
Alexidine (ALX) is an antimicrobial of the biguanide class, and contains ethylhexyl end
groups. This structure favors hydrophobic penetration into membrane lipids and elec-
trostatic adhesion to the negative sites of cell membranes resulting in bactericidal ac-
tivity. The systematic review by Serrano and colleagues26 identified 2 articles and
evaluated the adjunctive effect of ALX to toothbrushing in the prevention of plaque
accumulation and gingival inflammation in studies with duration of 6 months or longer.
The study outcome with respect to the Quigley and Hein36 Plaque Index (PI) scores at
the conclusion of the individual studies demonstrated a significant difference of means
(DiffM) of 0.16, with nonsignificant heterogeneity (I2 5 39.5%). Data with respect to
Table 1
Overview of the characteristics of the included systematic reviews processed for data extraction
Author, (Year),
Ingredient Databases Searched
No. of Included Studies/
Trails, No. Involved
Participants Base (End)
Leading Mode
of Analysis
Original Review Authors’
Conclusions
Comments of the Meta-
Review Authors
Serrano et al,26
2015
Multiple
ingredients
 PubMed ? studies
? (?)
Meta-analysis Formulations with specific
agents for chemical plaque
control provide statistically
significant improvements
in terms of gingival
bleeding and plaque
indices.
TCL was assessed in the meta-
analysis as a “pre-rinse” to
toothbrushing, which is
considered to provide an
“indirect” effect because
this is not a common daily
oral hygiene habit.
Van Leeuwen
et al,30 2014
EO
 PubMed-Medline
 Cochrane-CENTRAL
 EMBASE
5 studies
605 (534)
Meta-analysis EOs produce an effect on
plaque and gingivitis that
extends beyond the vehicle
solution.
Comparisons with vehicle
control are frequently
done with 5% hydro-
alcohol, whereas a true
placebo would contain
21.6%–26.9% alcohol.
Van Maanen-
Schakel et al,29
2012
CHX 1 H2O2
 PubMed-Medline
 Cochrane-CENTRAL
 EMBASE
 Trial registers
 Others
4 studies
252 (229)
Meta-analysis There is moderate evidence
that a combination of CHX
and an OA reduces tooth
staining without
interfering with plaque
growth inhibition.
Tooth discoloration was
considered as the primary
outcome variable and
plaque and gingivitis as
secondary.
Van Strydonck
et al,18 2012
CHX
 PubMed-Medline
 Cochrane-CENTRAL
 EMBASE
30 studies
34 experiments
3554 (2965)
Meta-analysis There is strong evidence for
the antiplaque and
antigingivitis effects of a
CHX rinse as an adjunct to
regular oral hygiene in
gingivitis patients;
however, a significant
increase in staining score
was seen by CHX
mouthrinse.
Staining as a side effect of
CHX can affect patient
compliance.
(continued on next page)
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(continued )
Author, (Year),
Ingredient Databases Searched
No. of Included Studies/
Trails, No. Involved
Participants Base (End)
Leading Mode
of Analysis
Original Review Authors’
Conclusions
Comments of the Meta-
Review Authors
Van Leeuwen
et al,31 2011
EO vs CHX
 PubMed-Medline
 Cochrane
19 studies
827 (?)
Meta-analysis Long-term studies showed
that CHX mouthwash was
statistically more effective
than EO with respect to
plaque control; however,
there was no significant
difference with respect to
reduction of gingival
inflammation. Also,
significantly more staining
was observed with CHX
compared with EO.
The evidence suggests that
EO acts primarily through
an anti-inflammatory
process and is a reliable
alternative to CHX for
long-term control of
gingival inflammation.
Hossainian
et al,28 2011
H2O2
 PubMed-Medline
 Cochrane-CENTRAL
 EMBASE
10 studies
12 experiments
384 (363)
Descriptive
analysis
H2O2 mouthwashes do not
consistently prevent
plaque accumulation when
used as a short-term
monotherapy. When used
as a long-term adjunct to
daily oral hygiene, the
results of one study
indicate that oxygenating
mouthwashes reduce
gingival redness.
A side effect of painful
sensation in the mouth
and/or erosive changes of
the oral mucosa may occur.
Gunsolley,23,24
2006, 2010
Multiple
ingredients
 Medline
 Unpublished studies
? studies
? (?)
Meta-analysis The studies provide strong
evidence of the antiplaque
and antigingivitis effects of
multiple agents. It supports
the use of mouthwashes as
part of a daily oral hygiene.
The review methodology is
unclear.
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Afennich et al,27
2011
HEX
 PubMed-Medline
 Cochrane- CENTRAL
 EMBASE
6 studies
357 (336)
Descriptive
analysis
HEX mouthwashes provide
better effects regarding
plaque reduction than
placebo mouthwashes.
They are less effective than
CHX.
Higher HEX concentrations
cause more side effects
compared with lower
concentrations.
Berchier et al,32
2010
CHX
0.12% vs 0.2%
 PubMed-Medline
 Cochrane
8 studies
10 experiments
803 (?)
Meta-analysis In the comparison, 0.12%
and 0.2% CHX information
concerning the effect on
gingival inflammation was
sparse. With respect to
plaque inhibition, the
results showed a small but
significant difference in
favor of the 0.2% CHX
concentration.
The clinical relevance of the
difference between the 2
concentrations was
considered negligible.
Several subanalyses are
performed, such as rinsing
duration, mouthwash
solution with/without
alcohol, manufacturer.
Haps et al,33
2008
CPC
 PubMed-Medline
 Cochrane
8 studies
867 (?)
Meta-analysis When used as an adjunct to
either supervised or
unsupervised oral hygiene,
CPC-containing mouth
rinses provide a small but
significant additional
benefit in reducing plaque
accumulation and gingival
inflammation.
The bioavailability and
concentration of the active
ingredient may influence
its clinical efficacy.
Addy et al,25
2007
DEL
 Unknown 8 studies
913 (?)
Pooled weighted
point estimate
DEL is effective as an adjunct
measure for reducing
plaque burden and indices
of gingivitis, whether or
not it is used under
supervision.
No common method for
meta-analysis was used.
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Ing dient Databases Searched
No. of Included Studies/
Trails, No. Involved
Participants Base (End)
Leading Mode
of Analysis
Origin l Review Authors’
Concl ions
Comments of the Meta-
Review Authors
Sto ken et al,34
2 07
EO
 PubMed-Medline
 Cochrane
11 studies
2810 (2515)
Meta-analysis EO pr ides an additional
ben fit to unsupervised
ora ygiene with regard to
pla e and gingivitis
red tion as compared
wit a placebo or control.
Comparisons are also made
to 5% hydro-alcohol, CHX
and a group that uses floss.
Pa skevas &
v n der
Weijden,35
2 06
Sn
 PubMed-Medline
 Cochrane-CENTRAL
 EMBASE
3 studies concerning
mouthwashes
781 (500)
Descriptive
analysis
With gard to SnF2, there is
insu ficient information on
gin vitis and plaque to
mak any conclusions.
The effect of the combined
use of SnF2
dentifrice 1 SnF2
mouthwash would be of
interest.
Abbr iations: ?, unknown; CHX, chlorhexidine; CPC, cetylpyridinium chloride; DEL, delmopinol; EO, es ntial oils; H2O2, hydrogen peroxide; HEX, hexetidine; OA,
oxyg ating agents; SnF2, stannous fluoride; TCL, triclosan.
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Estimated the risk of bias by scoring a list of items related to the reporting and methodological quality of the included systematic reviews
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Defined
outcome
criteria of
interest
1 1 1 1 1 1 1 1 1 1 1 1 1
Describes the
rationale
1 1 1 1 1 1 1 1 1 1 1 1 1
Describes the
focused (PICO)
[S] question/
hypothesis
1 1 1 1 1 1 1 1 1 1 1 1 1
Describes if a
protocol was
developed “a
priori”
       1     
Protocol
registration/
publication
       ?     
Presented
eligibility
criteria (in/
exclusion
criteria)
1 1 1 1 1 1 1 1 1 1 1 1 1
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subanalyses
1 1 1  1 1  1 1 1  1 1
Grading of the
obtained
evidence
          1 1 1
Present
limitations of
the systematic
review
     1 1 1 1  1 1 1
Provide a
conclusion
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objective
1 1 1 1 1 1 1 1 1 1 1 1 1
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2
Publication bias
assessed
       1   1 1 1
Funding source  1 1 1  1  1 1 1 1 1 1
Conflict of
interest
statement
1 1 1   1  1 1 1 1 1 1
Original authors
estimated level
of evidence
NR NR NR NR NR NR NR NR NR NR Moderate Moderate Strong
Current authors
estimated
quality score
52% 74% 78% 52% 70% 78% 63% 85% 81% 78% 85% 93% 89%
Current authors
estimated risk
of bias
Substantial Moderate Moderate Substantial Moderate Moderate Moderate Low Low Moderate Low Low Low
Each of the above items of the reporting and methodological quality item score list was given a rating of a plus (1) for informative description of the item at issue and a
study design meeting the quality standard was assigned, plus-minus () was assigned if the item was incompletely described, ? when unknown, and minus () was used
if the item was not described at all.19
For the quality assessment score, individual items with a positive rating were summed to obtain an overall percentage score.
Abbreviations: f.i; for instance; NR, not reported.
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Table 3
Overview of data extraction of the included systematic reviews regarding plaque index scores
Source Outcomes Heterogeneity
Ingredient Systematic Reviews No. Experiments Included in MA Difference of Means 95% CI P I2, % Pa
ALX Serrano et al,26 2015 2 0.16 0.25 to 0.08 <.0001 39.5 ns
CPC Gunsolley,24 2006 7 15.4% [] [] [] []
Haps et al,33 2008 7 0.35 0.47 to 0.24 <.00001 71.6 .002
Serrano et al,26 2015 10 0.39 0.54 to 0.24 <.0001 93.9 .000
CHX Gunsolley,24 2006 6 40.4% [] [] [] []
Van Strydonck et al,18 2012 5 0.68 0.85 to 0.51 <.00001 60.0 .06
Serrano et al,26 2015 3 0.64 0.76 to 0.52 <.0001 47.4 ns
DEL Addy et al,25 2007 8 0.34 0.39 to 0.29 <.00001 [] []
Serrano et al,26 2015 3 0.14 0.23 to 0.06 .001 0 ns
EO Gunsolley,24 2006 25 27.0% [] [] [] []
Stoeken et al,34 2007 7 0.83 1.13 to 0.53 .00001 96.1 <.00001
Serrano et al,26 2015 9 0.83 1.05 to 0.60 .000 97.0 .000
HEX Afennich et al,27 2011 [] [] [] [] [] []
OA Hossainian et al,28 2011 [] [] [] [] [] []
SAN Serrano et al,26 2015 1 12.1% [] [] [] []
SnF2 Paraskevas & van der
Weijden,35 2006
[] [] [] [] [] []
Serrano et al,26 2015 2 0.08 0.26 to 0.10 ns 60.9 ns
TCL Serrano et al,26 2015 3 0.68 0.85 to 0.51 <.0001 68.0 .04
0.12% CHX vs 0.2% CHX Berchier et al,32 2010 9 0.10 0.17 to 0.03 .008 0 ns
EO vs CHX Van Leeuwen et al,31 2011 5 0.19 0.30 to 0.08 <.0009 0 ns
OA plus CHX Van Maanen-Schakel
et al,29 2012
3 0.10 0.17 to 0.04 .003 0 .97
Abbreviations: [], no data available; ALX, alexidine; CHX, chlorhexidine; CPC, cetylpyridinium chloride; DEL, delmopinol; EO, essential oils; H2O2, hydrogen peroxide;
HEX, hexetidine; MA, meta analyzis; OA, oxygenating agents; SAN, sanguinarine; SnF2, stannous fluoride; TCL, triclosan.
a P>.1 is not significant (NS).
V
a
n
d
e
r
W
e
ijd
e
n
e
t
a
l
8
1
4
Table 4
Overview of data extraction of the included systematic reviews regarding the Gingival Index scores
Source Outcomes Heterogeneity
Ingredient Systematic Reviews No. Experiments Included in MA Difference of Means 95% CI P I2, % Pa
ALX Serrano et al,26 2015 1 0.09 024 to 0.07 ns [] []
CPC Gunsolley,24 2006 6 13.4% [] [] [] []
Haps et al,33 2008 7 0.15 0.23 to 0.07 .0003 87.0 <.0001
Serrano et al,26 2015 4 0.33 0.53 to 0.12 .002 95.3 .000
CHX Gunsolley,24 2006 6 28.7% [] [] [] []
Van Strydonck et al,18 2012 3 0.24 0.29 to 0.20 <.00001 87.0 .0005
Serrano et al,26 2015 6 0.17 0.25 to 0.08 <.0001 59.5 .03
DEL [] [] [] [] [] [] []
EO Gunsolley,24 2006 24 18.2% [] [] [] []
Stoeken et al,34 2007 8 0.14 0.25 to 0.03 <.00001 75.4 .02
Serrano et al,26 2015 2 0.13 0.19 to 0.07 <.0001 45.1 ns
HEX Affenich et al,27 2011 [] [] [] [] [] []
OA Hossainian et al,28 2011 [] [] [] [] [] []
SAN Serrano et al,26 2015 1 2.8% [] [] [] []
SnF2 Paraskevas & van der
Weijden,35 2006
[] [] [] [] [] []
Serrano et al,26 2015 2 0.25 0.43 to 0.07 .007 54.2 ns
TCL Serrano et al,26 2015 3 0.27 0.31 to 0.24 <.0001 41.0 ns
0.12% CHX vs 0.2% CHX Berchier et al,32 2010 [] [] [] [] [] []
EO vs CHX Van Leeuwen et al,31 2011 4 0.03 0.16 to 0.09 ns 62.0 .05
OA plus CHX Van Maanen-Schakel
et al,29 2012
[] [] [] [] [] []
Abbreviations: [], no data available; ALX, alexidine; CHX, chlorhexidine; CPC, cetylpyridinium chloride; DEL, delmopinol; EO, essential oils; H2O2, hydrogen peroxide;
HEX, hexetidine; MA, meta analyzis; OA, oxygenating agents; SAN, sanguinarine; SnF2, stannous fluoride; TCL, triclosan.
a P>.1 is not significant (NS).
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Van der Weijden et al816the Gingival Index (GI37) were based on one study and showed a nonsignificant mean
difference of 0.09 as compared with the control group.
Cetylpyridinium chloride
Cetylpyridinium chloride (CPC) is a cationic quaternary ammonium compound with
surface-active properties. Its mechanism of action relies on the hydrophilic part of
the CPC molecule interacting with the bacterial cell membrane leading to loss of
cell components, disruption of cell metabolism, inhibition of cell growth, and finally
cell death. It has a broad antimicrobial spectrum, with rapid killing of gram-positive
pathogens and yeast in particular. CPCmay cause brown staining of teeth. The search
retrieved 3 systematic reviews concerning the efficacy of CPC evaluating the adjunc-
tive effect to toothbrushing in the prevention of plaque accumulation and gingival
inflammation. The systematic review by Gunsolley23,24 identified 7 articles in studies
with a duration of 6 months or longer. The study outcome with respect to the PI at
the finish of the individual studies demonstrated a weighted mean percentage reduc-
tion of 15.4% (SD 7.6). Data with respect to the GI showed weighted mean percentage
reduction of 13.4% (SD 8.7).
The systematic review by Haps and colleagues33 identified 8 articles in studies of
4 or more weeks’ duration. The meta-analysis of PI scores at the end of the individual
studies demonstrated a significant DiffM of 0.35, with moderate heterogeneity
(I2 5 71.6%). Data with respect to the GI showed a significant DiffM of 0.15 in favor
of CPC as compared with the control group (considerable heterogeneity, I2 5 87%).
The most recent systematic review by Serrano and colleagues26 identified 10 articles
in studies of 6 or more months’ duration. The study outcome with respect to the PI
scores at the finish of the individual studies demonstrated a significant DiffM of
0.39, with considerable heterogeneity (I2 5 93.9%). Data with respect to the GI
showed a significant DiffM of 0.33 in favor of CPC as compared with the control
group (considerable heterogeneity, I2 5 95.3%).
Chlorhexidine
Chlorhexidine (CHX) is a cationic bisbiguanide that is active against gram-positive and
gram-negative organisms, facultative anaerobes, aerobes, and yeasts. CHX lasts
longer in the mouth than other mouthwashes (substantivity) and can cause stains
on teeth, tongue, gingiva, and resin restorations. Prolonged use also can reduce bitter
and salty taste sensations. CHX was first investigated more than 50 years ago and is
currently one of the most widely used and thoroughly evaluated oral topical
antiseptics.
The search retrieved 3 systematic reviews concerning the efficacy of CHX evalu-
ating the adjunctive effect against toothbrushing in the prevention of plaque accumu-
lation and gingival inflammation. The systematic review by Gunsolley23,24 identified 6
articles in studies of 6 or more months’ duration. The study outcome with respect to
the PI at the finish of the individual studies demonstrated a weighted mean percentage
reduction of 40.4% (SD 11.5). Data with respect to the GI37 showed weighted mean
percentage reduction of 28.7% (SD 6.5).
The systematic review by Van Strydonck and colleagues18 identified 30 articles and
evaluated the adjunctive effect of CHX to toothbrushing in the prevention of plaque
accumulation and gingival inflammation in patients with gingivitis, including studies
of 4 or more weeks’ duration.
The meta-analysis of PI scores at the finish of the individual studies considered by
the authors to be at “low risk” demonstrated a DiffM of 0.68, heterogeneity was not
significant (I25 60%). Data with respect to the GI showed a DiffM of 0.24, in favor of
Chemical Mouthwash Agents in Plaque/Gingivitis Control 817CHX as compared with the control rinse (considerable heterogeneity, I25 87%). Rela-
tive to control, the reduction with CHX for plaque was calculated to be 33% and for
gingivitis 26%. The CHX rinsing groups demonstrated significantly more staining.
The most recent systematic review by Serrano and colleagues26 identified 14 arti-
cles in studies of 6 or more months’ duration. The study outcome with respect to
the PI scores at the finish of the individual studies demonstrated a significant DiffM
of 0.64, with nonsignificant heterogeneity (I2 5 47.4%). Data with respect to the GI
showed a significant DiffM of 0.17, in favor of CHX as compared with the control
group (considerable heterogeneity, I2 5 95.3%).
Delmopinol
Delmopinol, an amino alcohol, is a third-generation antiplaque agent used as a mouth-
wash to reduce plaque and alleviate gingivitis. It has surface-active properties and
creates an environment that will not allow plaque biofilm and bacteria to adhere.
The search retrieved 2 systematic reviews concerning the efficacy of CHX evalu-
ating the adjunctive effect to toothbrushing in the prevention of plaque accumulation
and gingival inflammation. The systematic review by Addy and colleagues25 identified
8 studies with durations ranging from 8 to 24 weeks. Analyses for plaque and gingivitis
based on aggregated data confirm the efficacy of delmopinol 0.2% over the placebo
for PI scores, demonstrating a significant DiffM of 0.34. Data with respect to the GI
were not available. Modified gingival index38 scores and bleeding on probing (BOP)
scores also showed a significant effect on gingivitis. Analysis also revealed no sus-
tained heterogeneity of outcome, although the variable of BOP ranged considerably
across the studies from less than 10% to greater than 30% (DiffM 2.8%).
The most recent systematic review by Serrano and colleagues26 identified 3 articles
in studies of 6 or more months’ duration. The study outcome with respect to the PI
scores at the finish of the individual studies demonstrated a significant DiffM of
0.14, with nonsignificant heterogeneity (I2 5 0%). Data with respect to the GI were
not available. Modified GI38 scores and BOP scores indicate a nonsignificant effect
on gingivitis.
Essential oils
Essential oils (EOs) are used in an over-the-counter mouthwash containing a fixed
formula of 2 phenol-related EOs, thymol 0.064% and eucalyptol 0.092%, mixed
with menthol 0.042% andmethyl salicylate 0.060% in a 22% alcohol vehicle. The anti-
microbial mechanisms of action of EO against bacteria are complex. At high concen-
trations, there is disruption of the cell wall and precipitation of cell proteins, whereas
at lower concentrations, there is inactivation of essential enzymes. Also, anti-
inflammatory action has been proposed based on antioxidant activity. EOs also
may cause staining of teeth.39,40 The search retrieved 3 systematic reviews concern-
ing the efficacy of EO evaluating the adjunctive effect to toothbrushing in the preven-
tion of plaque accumulation and gingival inflammation. The systematic review by
Gunsolley23,24 identified 20 articles with a study duration of 6 or more months
including unpublished data. The study outcome with respect to the PI at the finish
of the individual studies demonstrated a weighted mean percentage reduction of
27% (SD 11.0). Data with respect to the GI showed weighted mean percentage
reduction of 18.2% (SD 9.0).
The systematic review by Stoeken and colleagues34 identified 11 studies with dura-
tions of 6 or more months. The study outcome with respect to the PI scores at the
finish of the individual studies demonstrated a significant DiffM of 0.83, with consid-
erable heterogeneity (I2 5 96.1%). Data with respect to the (modified) GI showed a
Van der Weijden et al818significant DiffM of 0.14 in favor of CHX as compared with the control group (mod-
erate heterogeneity, I2 5 75.4%). The most recent systematic review by Serrano and
colleagues26 identified 15 articles including studies of 6 or more months’ duration. The
study outcome with respect to the PI scores at the finish of the individual studies
demonstrated a significant DiffM of 0.14, with nonsignificant heterogeneity
(I2 5 0%). Data with respect to the GI showed a significant (P<.0001) DiffM of 0.13
in favor of CHX as compared with the control group (nonsignificant heterogeneity,
I2 5 45.1%). Differences in modified GI scores also were significant and more pro-
nounced (DiffM 0.54, 95% CI 0.76 to 0.31).
Hexetidine
Hexetidine (HEX) belongs to the group of pyrimidine derivatives. It is a broad-spectrum
antiseptic, active in vitro and in vivo against gram-positive and gram-negative bacteria
as well as yeast. However, oral retention appears to be limited so that the antimicrobial
activity does not last long. The systematic review by Afennich and colleagues27 iden-
tified 6 articles and evaluated the adjunctive effect of HEX to toothbrushing in the pre-
vention of plaque accumulation and gingival inflammation in short-term (4 weeks)
and long-term (4 weeks) study designs. The data that were retrieved did not allow
for a meta-analysis. Therefore, a descriptive analysis was presented that showed
that both in the short and long term, antiplaque effects can be expected; however,
no concomitant effect on GI scores was observed.
Oxygenating agents
Oxygenating agents (OAs), such as hydrogen peroxide (H2O2), buffered sodium per-
oxyborate, and peroxycarbonate, have been recommended for short-term use as dis-
infectants. They exert antimicrobial effects through the release of oxygen. The
systematic review by Hossainian and colleagues28 identified 10 articles and evaluated
the adjunctive effect of OA to toothbrushing in the prevention of plaque accumulation
and gingival inflammation in short-term (4 weeks) and long-term (4 weeks) study
designs. The data that were retrieved did not allow for a meta-analysis. Therefore, a
descriptive analysis was presented that showed that OA mouthwashes do not consis-
tently prevent plaque accumulation when used as a short-term monotherapy. When
used as a long-term adjunct to daily oral hygiene, the results of one study indicate
that OA mouthwash reduces gingival redness.
Sanguinarine
Sanguinarine (SAN) is a (toxic) quaternary ammonium salt from the group of benzyli-
soquinoline alkaloids. It is extracted from some plants, including bloodroot (Sangui-
naria canadensis). It is also found in the root, stem, and leaves of the opium poppy.
The systematic review by Serrano and colleagues26 identified 1 article evaluating
the adjunctive effect of SAN to toothbrushing in the prevention of plaque accumulation
and gingival inflammation with 6 months’ duration. The study outcome with respect to
the PI at the finish of the study demonstrated a significant mean difference of 12.1%
versus placebo and data with respect to the GI showed a nonsignificant mean differ-
ence of 2.8%.
Stannous fluoride
Tin fluoride, commonly referred to commercially as stannous fluoride (SnF2) is a well-
known agent that has been used in dentifrice formulations as early as the beginning of
the 1940s. Apart from reducing the incidence of dental caries, it has antimicrobial ef-
fects and as such has been formulated in mouthwashes. The combination of tin and
fluoride is difficult to formulate because of limited stability in an aqueous solution.
Chemical Mouthwash Agents in Plaque/Gingivitis Control 819SnF2 may cause a yellowish-brown staining of teeth. The search retrieved 2 system-
atic reviews concerning the efficacy of SnF2 evaluating the adjunctive effect to tooth-
brushing in the prevention of plaque accumulation and gingival inflammation. The
systematic review by Paraskevas and van derWeijden35 identified 2 articles evaluating
mouthwashes in studies with a duration of 6 or more months. The data that were
retrieved did not allow for a meta-analysis. Therefore, a descriptive analysis was pre-
sented that showed that SnF2 mouthwashes do not consistently prevent plaque accu-
mulation or prevent gingivitis. The most recent systematic review by Serrano and
colleagues26 identified 3 articles in studies of 6 or more months’ duration. The study
outcome with respect to the PI scores at the finish of the individual studies demon-
strated a nonsignificant DiffM of 0.08, with nonsignificant heterogeneity
(I2 5 60.9%). Data with respect to the GI showed a significant DiffM of 0.25 in favor
of CHX as compared with the control group (nonsignificant heterogeneity, I25 54.2%).
Triclosan
Triclosan (TCL) is a nonionic chlorinated aromatic compound that has functional
groups representative of both ethers and phenols. It has antibacterial and antifungal
properties and is applied in consumer products, including soaps and detergents. In
mouthwash products it is combined with either zinc sulfate or a copolymer. The sys-
tematic review by Serrano and colleagues26 identified 4 articles that evaluated the
adjunctive effect of TCL as pre-rinse to toothbrushing in the prevention of plaque
accumulation and gingival inflammation in studies of 6 or more months’ duration.
The study outcome with respect to the PI scores at the finish of the individual studies
demonstrated a significant DiffM of 0.68, with moderate heterogeneity (I2 5 68%).
Data with respect to GI showed a significant DiffM of 0.27 in favor of TCL as
compared with the control group (nonsignificant heterogeneity, I2 5 41.0%).
Comparisons of Active Ingredients
Chlorhexidine 0.12% versus chlorhexidine 0.2%
In their systematic review, Berchier and colleagues32 identified 8 articles evaluating
the 2 CHX concentrations in relation to the prevention of plaque accumulation and
gingival inflammation with no limits to study duration. With respect to the PI scores
at the finish of the individual studies demonstrated a significant (P 5 .008) DiffM of
0.10 (95% CI 0.17 to 0.03), in favor of 0.2% CHX with nonsignificant heterogene-
ity (I25 0%). The investigators considered the clinical relevance of this difference likely
to be negligible. Information concerning the effect on gingival inflammation was
sparse. Descriptive analysis tended to show that there was no difference.
Essential oils versus chlorhexidine
The systematic review by Van Leeuwen and colleagues31 identified 19 articles that
evaluated the adjunctive effect of EO mouthwash against CHX in short-term (4
weeks) and long-term (4 weeks) study designs. Long-term studies evaluating the
adjunctive effect to toothbrushing showed that, at the end of the studies, PI scores
were reduced significantly (P<.0009) with DiffM of 0.19 (95% CI 0.30 to 0.08),
in favor of CHX as compared with the EO group with nonsignificant heterogeneity
(I2 5 0%). Data with respect to GI showed a nonsignificant DiffM of 0.03 (95% CI
0.16–0.09) with moderate heterogeneity (I2 5 62%, P 5 .05).
Essential oil versus alcohol solution
The systematic review by Van Leeuwen and colleagues30 identified 5 articles that eval-
uated the adjunctive effect of EO mouthwash against an alcohol vehicle solution of
21.6 or 26.9% hydro-alcohol (V-Sol) in short-term (4 weeks) and long-term
Van der Weijden et al820(4 weeks) study designs. Long-term studies evaluating the adjunctive effect to tooth-
brushing showed with respect to the PI scores at the finish of the individual studies a
significant (P<.00001) DiffM of 0.39 (95% CI 0.47 to 0.30), in favor of EO with
nonsignificant heterogeneity (I2 5 0%). Data with respect to GI showed, in favor of
EO, a significant (P<.00001) DiffM of 0.36 (95% CI 0.62 to 0.26), with consider-
able heterogeneity (I2 5 92%, P<.00004).
Hexetidine versus chlorhexidine
In their systematic review Afennich and colleagues27 (see earlier in this article) showed
in their descriptive analysis that HEX is consistently less effective in plaque reduction
than a CHXmouthwash and also less effective in reducing gingival inflammation than a
CHX mouthwash.
Oxygenating agents versus chlorhexidine
In their systematic review, Hossainian and colleagues28 (see earlier in this article)
showed in their descriptive analysis that OAs are consistently less effective in plaque
reduction than a CHX mouthwash.
Combination of Active Ingredients
Chlorhexidine and oxygenating agents
In their systematic review, Van Maanen-Schakel and colleagues29 identified 4 articles
that evaluated the adjunctive effect of OA in combination with CHX in relation to the
prevention of plaque accumulation and gingival inflammation with no limits to study
duration. In their descriptive analysis, CHX in combination with OA showed no consis-
tent difference in plaque or gingivitis reduction as compared with CHX mouthwash
alone. Meta-analysis concerning the Silness and Lo¨e PI (1964) showed a significant
DiffM in favor of the combination (DiffM 0.10, 95% CI 0.17 to 0.04) with nonsig-
nificant heterogeneity (I2 5 0%). However, a significant (P 5 .02) reduction in staining
was observed in the combination with OA (DiffM0.27, 95% CI0.49 to0.05]), with
nonsignificant heterogeneity (I2 5 38%, P 5 .20).
Evidence Profile
Table 5 shows a summary of the various factors used to rate the body of evidence and
strength of recommendations according to GRADE. There is strong evidence in sup-
port of the efficacy of both CHX and EO that have a large beneficial effect on plaque
reduction and a moderate effect on gingivitis. There is also strong evidence in support
of the efficacy of CPC, which has a moderate beneficial effect on both plaque and
gingivitis scores. There is moderate evidence for a small effect of ALX and for a large
effect of TCL when used as pre-rinse before toothbrushing. Weak evidence emerged
for small or indistinct effects of HEX, OA, SAN, and SnF2.
DISCUSSION
This meta-review summarized the available evidence as was present in the form of
systematic reviews with respect to the efficacy of mouthwash for plaque control in
managing gingivitis. We included only systematic reviews because there are many
such reviews available and this type of research generally provides more evidence
than separate empirical studies taken alone.15 There was strong consistent evidence
emerging from 3 systematic reviews that evaluated CHX and EO showing that these
ingredients are effective in plaque reduction. However, the evidence also shows mod-
erate to considerable heterogeneity in the meta-analysis. In cases in which heteroge-
neity is obvious, readers should exercise caution, as the DiffM may not provide an
Table 5
Estimated evidence profile21 for the effect of various active ingredients of mouthwashes on d ntal plaque and gingival health
GRADE ALX CPC CHX DEL EO HEX OA SAN SnF2 TCL
Study Designs
Systematic
Review
n 5 1
Systematic
Review
n 5 3
Systematic
Review
n 5 3
Systematic
Review
n 5 2
Systematic
Review
n 5 3
Sys matic
Rev w
n 5
Systematic
Review
n 5 1
Systematic
Review
n 5 1
Systematic
Review
n 5 2
Systematic
Review
n 5 1
Reporting and
methodological
estimated
potential risk
of bias
Low Low to
Substantial
Low to
Substantial
Substantial Low to
Substantial
Mo rate Moderate Low Low to
Moderate
Low
Consistency Inconsistent Consistent Consistent Fairly
consistent
Consistent Inco sistent Inconsistent Inconsistent Inconsistent Consistent
Heterogeneity ND Considerable Considerable ND Considerable ND ND ND Moderate Moderate
Directness Direct Direct Direct Direct Direct Ind ct Indirect Direct Direct Indirect
Precision Precise Precise Precise Imprecise Precise Imp cise Imprecise Imprecise Imprecise Precise
Publication bias Possible Possible Possible Possible Possible Pos le Possible Possible Possible Possible
Magnitude of the
effect
Small Moderate Large Small Large Ind inct Indistinct Small Small large
Body of evidence Moderate Strong Strong Weak Strong We Weak Weak Weak Moderate
Abbreviations: ALX, alexidine; CHX, chlorhexidine; CPC, cetylpyridinium chloride; DEL, delmopino EO, essential oils; HEX, hexetidine; ND, not determinable; OA,
oxygenating agents; SAN, sanguinarine; SnF2, tin (stannous) fluoride; TCL, triclosan.
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Van der Weijden et al822exact measure of the results. It is therefore difficult to compare these 2 chemical
agents based on the DiffM or make inferences that one ingredient would be more
effective than the other. Only one review emerged that compared mouthwash ingredi-
ents31 with a moderate estimated risk of bias and a quality score of 78%. It showed
that in comparison to EO, CHX provided better results for plaque control. For the
long-term control of gingival inflammation, EO was not different from CHX.
Grading
The steps toward guideline development involve formulating recommendations that
clinicians and their patients should follow.41 A variety of systems are used to rate
the quality of the evidence underlying their recommendations. The GRADE working
group has developed a common, sensible, and transparent approach to grading qual-
ity of evidence and strength of recommendations. Many international organizations
have provided input into the development of the approach and have started using
it. The strength of a recommendation indicates the extent to which one can be confi-
dent that the desirable effects of an intervention outweigh its undesirable effects.
When a recommendation is weak, clinicians and other health care providers need to
devote more time to the process of shared decision-making by which they ensure
that the informed choice reflects individual values and preferences. This is likely to
involve ensuring patients understand the implications of the choices they are making,
possibly by using a formal decision aid. When recommendations are strong, clinicians
may spend less time on the process of making a decision, and focus efforts on over-
coming barriers to implementation or adherence. However, the strength of a recom-
mendation may not be directly correlated with its priority for implementation.42
Alternatively, in considering 2 or more possible management strategies, a recommen-
dation’s strength represents the confidence that the net benefit clearly favors one
alternative or another. From this meta-review, 2 chemical agents emerged for which
strong evidence with a large effect was available to recommend their use in mouth-
wash products. These were CHX and EO.
Side Effects
Various side effects have been reported for mouthwash products of which staining is a
more common complaint following use of CHX, CPC, delmopinol (DEL) EO, and SnF2.
The staining can become worse when other products that are known to cause stain-
ing, such as tea, coffee, wine, and cigarettes, are consumed at the same time. One
systematic review included in this meta-analysis showed that there is moderate evi-
dence that a combination of CHX and an OA reduces tooth staining and also showed
that it slightly but significantly increases inhibition of plaque growth.29 Another issue is
taste disturbance, which has been attributed to CHX, CPC, DEL EO, SAN, and HEX.
For instance CHX, which tastes bitter, greatly reduces the perceived intensity of the
salt.43 The development of taste disturbance and tooth staining and the promotion
of calculus formation does not permit the widespread long-term use of CHX as a daily
adjunct to normal oral hygiene procedures.18 CHX is therefore rather restricted to
short-term to moderate-term use and in special clinical situations. A rare side effect
that can be disturbing to the patient is parotid swelling, which has been reported after
the use of both HEX and CHX.44 The investigators of this case report concluded that
parotid swelling may not be related to the type of mouthwash used, but may instead
be a consequence of the rinsing action itself. Another potential adverse effect is a shift
in the type or quantity of oral commensals. Virtually all of the main chemical plaque-
control agents do not produce major shifts or development of resistant strains.
When, on rare occasion, adverse effects on the oral microflora emerge, these effects
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reported for SAN, which is suspect for causing the formation of white lesions.46
Although the available clinical and animal data provide no support that the use of a
SAN mouthwash is causally associated,47 its production has been discontinued.48
Chlorhexidine and sodium lauryl sulfate
Chemicals in mouthwash and dentifrice formulations can result in antagonism with
reduction or negation of activity of one or both chemicals. In the broad search, 2 sys-
tematic reviews surfaced concerning the negative impact dentifrices containing so-
dium lauryl sulfate (SLS) may have on the efficacy of CHX mouthwash on the
prevention of plaque accumulation and gingival inflammation. This interaction is not
restricted to just CHX but any cationic antiseptic-containing mouthwash, such as
CPC, making it essential that active mouthwash ingredients are evaluated for bioavail-
ability under normal use. SLS is the most commonly used surfactant in dentifrices that,
in addition to other properties, enhance the dentifrice foaming action. In their system-
atic review Kolahi and Soolari49 identified an unclear number of articles that evaluated
the effect of SLS in combination with CHX in relation to the prevention of plaque accu-
mulation and gingival inflammation with no limits to study duration. There was not
sufficient similarity between the included trails to combine them in a formal meta-
analysis. Hence, the investigators declare that they used best evidence synthesis as
an intelligent alternative for meta-analysis. They concluded that there are adequate
reasons to believe CHX and SLS dentifrices are not compatible. Also, besides SLS,
CHX may not be compatible with many anionic compounds found in dentifrices.50
More recently, Elkerbout and colleagues51 also evaluated the effect of SLS in combi-
nationwithCHX in relation to theprevention of plaqueaccumulation andgingival inflam-
mation with no limits to study duration and identified 4 articles. The study outcomewith
respect to the PI scores at the finish of the individual studies demonstrated a nonsignif-
icant DiffM of0.08 (95%CI0.26–0.11), with nonsignificant heterogeneity (I25 0%).
No analysis with respect to gingivitis scores could be performed. The investigators
concluded that there is moderate evidence to state that SLS dentifrice can be freely
used in combination with CHX. Van Strydonck and colleagues18 also noted that in
most of the studies in their review CHX was always combined with regular oral hygiene
procedures. However, this usage still showed a beneficial effect on oral health, which
indicates that the impact of SLS may not be clinically relevant.
Substantivity and bioavailability
Mouthwashes are simply a means for delivery of active substances in the oral cavity
where, after 20 to 30 seconds of rinsing, all surfaces of the dentition have come into
contact with the mouthwash.52 Most are composed of a water or water-alcohol
base, with flavor, surfactant, and humectant added for their cosmetic properties.
Mouthwashes and their active ingredients are exposed to the mouth for a relatively
short period of time before expectoration from themouth. In addition, the proteins pre-
sent in saliva may reduce the activity of some substances.53 The property of substan-
tivity ensures that, at least for some chemicals (such as CHX), possible antibacterial
effects are sustained for much longer periods of time.45 Substantivity refers to the abil-
ity of an agent to be retained in the oral cavity and to be released over an extended
period of time with retention of potency. The overall oral retention of an antiplaque
agent is determined by the strength and rate of association of the agent with its recep-
tor sites and the accessibility of these sites. The substantivity of an antiplaque agent
and its clearance from the oral cavity are determined by the rate of dissociation of the
agent from the receptor sites and the salivary composition and flow rate.9 CHX is well
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and the oral soft tissues from where it exerts a plaque inhibitory effect that, within
the oral cavity, may last up to 12 hours.54
It is noteworthy that the inclusion of a known active agent in a formulation does not
guarantee efficacy, although it is often used to make piggy-back claims for new prod-
ucts. For instance, 2 recent systematic reviews have shown that CHX can be success-
fully formulated into a dentifrice/gel and will inhibit plaque growth to some degree, but
not to the same extent as CHX incorporated into a mouthwash.55,56 Many oral hygiene
products are complex formulations, and the potential for ingredient interactions is
great. Bioavailability is an issue that deserves attention when formulating a mouth-
wash. Formulations with high bioavailable CPC are associated with greater biological
activity and therefore suggest an increased probability for clinical efficiency.57
Alcohol
Alcohol in mouthwashes is used to enhance flavor impact, to solubilize the flavor and
some active ingredients, to provide some preservative power, and improve the trans-
port of active ingredients into the dental plaque biofilm. The systematic review by Van
Leeuwen and colleagues30 indicated that the alcohol vehicle solution does not
contribute to the efficacy of the mouthwash. Although the accumulated effects of
mouthrinse usage with a high percentage of alcohol and ingestion of alcohol could
theoretically predispose toward oral or pharyngeal carcinoma, the contributory effects
of alcohol in these rinses are unclear and not considered proven58 by most national
regulatory organizations, including the US Food and Drug Administration.59
More recently, for various reasons, there has been an increase in the demand for
alcohol-free mouthwashes.60 An important determination is whether the inclusion or
exclusion of alcohol could affect the activity of the mouthwashes. In the meta-
analysis of Serrano and colleagues,26 10 studies evaluating EO included 9 mouthwash
products that contained alcohol and 1 that did not. Based on this limited evidence, no
major difference was observed (DiffM for alcohol 0.827 and mean difference alcohol
free 0.746). Berchier and colleagues,32 in their 0.12% versus 0.2% CHX article, per-
formed a subanalysis on 0.12% CHX with/without alcohol as compared with 0.2%
CHX with alcohol. The data show a trend that the nonalcohol product was slightly
less effective.
There has been concern that alcohol from mouthwash products is being converted
to acetaldehyde in the oral cavity, which thenmay cause DNA damage and lead tomu-
tations. A meta-analysis of epidemiologic studies concerning mouthwash and oral
cancer also specifically evaluating mouthwash products containing greater than
25% alcohol was performed by Gandini and colleagues.61 The meta-analysis included
18 studies. No statistically significant associations (relative risk [RR]) were found
between regular use of mouthwash and risk of oral cancer (RR 1.13; 95% CI 0.95–
1.35). There was also no association reported use of mouthwash specifically contain-
ing alcohol and risk of oral cancer (RR 1.16; 95% CI 0.44–3.08). Based on their
observations, the investigators came to the conclusion that based on the quantitative
analysis of mouthwash use and oral malignancy, no statistically significant associa-
tions were revealed between mouthwash use and risk of oral cancer, nor was any sig-
nificant trend observed in risk with increasing daily use, nor association between use
of mouthwash containing alcohol and oral cancer risk.
Rinse Duration and Volume
The manufacturers of mouthwash products recommend different durations for the
rinsing procedure. Keijser and colleagues62 compared mouthwashes with various
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shorter rinsing time, which raises the question of whether shorter rinsing times can
be sufficient for effective plaque control. Another study assessed the plaque-
inhibiting effect of a 0.2% CHX solution with 3 different rinsing times following a
72-hour nonbrushing period, this being 60 seconds as proposed by the manufac-
turer, and 2 shorter rinsing times of 30 seconds and 15 seconds.63 The outcome
did not reveal a significant difference in plaque development whether the subjects
rinsed for 60, 30, or 15 seconds, which suggests that even 15 seconds may be
long enough to reduce plaque levels. Berchier and colleagues32 also showed that
there is minimal difference between rinsing for 30 or 60 seconds on plaque scores.
Further studies are needed to establish whether shorter rinsing times will be sufficient
for effective gingivitis control. A consideration is that a shorter rinsing time could
have a positive effect on compliance. Manufacturers also recommend different vol-
umes, ranging from 10 to 20 mL. It seems relevant to have information about the
mouthwash volume that is understood by the patient to ensure optimal compliance.
One study assessed the volume of mouthwash with respect to patients’ perceptions
of comfort.64 This study investigated volunteers’ subjective perceptions to different
volumes of mouthwash (volumes of 5, 10, 15, 20, and 30 mL) to establish the
most comfortable volume of mouthwash with which to rinse. Based on the results
of this experiment with a nonfoaming mouthwash, it was concluded that the most
pleasant volume of mouthwash is 15 mL. This volume had a mean visual analogue
scale (VAS) score that was closest to the optimal score. The differences between
the mean VAS scores of rinsing with 15 mL and other volumes were statistically sig-
nificant (P<.001).Limitations of mouthwashes in the prevention of dental plaque formation
 The oral biofilm produces an encased and highly protective community of cells
that acts as a barrier and as a result is much less influenced by its environment,
including the introduction of chemical agents.65 This aspect has received little
attention in mouthwash studies.
 There appears to be a consensus that mouthwashes with antiplaque agents are
not designed to be used in isolation and should be used in combination with me-
chanical cleaning.8
 For individuals with existing disease with frank periodontal pocketing, the use of
vehicles such as mouthwash or dentifrice to deliver antimicrobial and antiplaque
agents has only limited or no effects on the subgingival flora.8,45 In these cases,
chemical agents need to be placed directly into the subgingival environment by
subgingival irrigation or by some alternative drug-release device. However,
within minutes, gingival crevicular fluid outflow will dilute subgingivally applied
antiseptics.66
 Only sparse information is available with respect to the efficacy of chemothera-
peutic agents on biofilm-contaminated titanium surfaces.67
 Mouthwashes can also act as a vehicle in which to incorporate chemicals that
promote fresh breath and help alleviate the problem of oral malodor. This aspect
was not addressed by this meta-analysis. Systematic reviews have shown that
due to very limited evidence, the potential effect of a specifically formulated
mouthwash for treating oral malodor is, in general, unclear.68,69
 Publication bias cannot be ruled out. The results as presented in this meta-review
may therefore provide a biased estimate of the true effect (overestimation)
because there is a tendency to publish mainly positive studies.
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The long-term adjunctive use of antiplaque agents in any vehicle other than dentifrice
would have significant cost implications to the average family. At present prices, the
cost of mouthwashes would be far greater than that of toothbrushes and dentifrice.
This may be prohibitive for many individuals, and dentifrice is thus still the best vehicle
for delivering antiplaque agents. Nonetheless, if a mouthwash is highly effective in
terms of oral health gain, the additional cost of its use may be a price worth paying.8
As emerged out of this review, this would apply particularly to CHX and EO
mouthwashes.SUMMARY
This meta-review summarized and appraised the current state of evidence based on
systematic reviews, with respect to the efficacy of various active ingredients of over-
the-counter chemotherapeutic mouthwash formulations for plaque control in manag-
ing gingivitis. Evidence suggests that a mouthwash containing CHX is the first choice.
The most reliable alternative for plaque control is EO. No difference between CHX and
EO with respect to gingivitis was observed.ACKNOWLEDGMENTS
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